SCHEMBL367222

SCHEMBL367222

NC(=O)c1cc(O)c2c(C(N)=O)c3ccccc3n2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.41
SRC P12931 2/20 0.41
PARP1 P09874 3/20 0.37
BAZ2B Q9UIF8 2/20 0.36
BAZ2A Q9UIF9 2/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
NPC1 O15118 3/20 0.35
LCK P06239 1/20 0.35
ELANE P08246 1/20 0.35
POLB P06746 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
RECQL P46063 1/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL365771 0.92 EGFR (0.43) EGFRSRCBAZ2BBAZ2AHTR2A
SCHEMBL365023 0.92 EGFR (0.40) EGFRSRCHTR2AHTR2CELANE
SCHEMBL367256 0.92 EGFR (0.40) EGFRSRCPARP1BAZ2BBAZ2A
SCHEMBL367766 0.81 L3MBTL1 (0.43) EGFRSRCPARP1NPC1MAPT
SCHEMBL366821 0.81 AGTR1 (0.41) EGFRSRCPOLBCYP3A4MAPT
SCHEMBL365789 0.79 EGFR (0.41) EGFRSRCBAZ2BBAZ2APOLB
SCHEMBL365256 0.76 EGFR (0.40) EGFRSRCNPC1TSHR
SCHEMBL367764 0.76 EGFR (0.45) EGFRSRCPARP1HTR2AHTR2C
SCHEMBL366567 0.76 PSEN1 (0.38) EGFRSRCPOLBMAPTTSHR
SCHEMBL366790 0.75 EGFR (0.41) EGFRSRCPOLBCYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO claimed
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO disclosed